REL-1017-304
Not Recruiting
99 years or below
All
Phase
N/A
1 Location
Brief description of study
A randomized, double-blind, placebo-controlled Phase 3 trial of REL-1017 in Major Depressive Disorder (MDD) as an adjunctive therapy
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Updated on
11 Sep 2024.
Study ID: 854675
